Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera

British Journal of Haematology

Volumn 135, Issue 1, 2006, Pages 129-138

  Weizer Stern, Orly ^a   Adamsky, Konstantin ^a   Amariglio, Ninette ^a   Levin, Carina ^b   Koren, Ariel ^b   Breuer, William ^c   Rachmilewitz, Eliezer ^d   Breda, Laura ^e   Rivella, Stefano ^e   Ioav Cabantchik, Z ^c   Rechavi, Gideon ^a,f  

^a TEL AVIV UNIVERSITY   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f SHEBA MEDICAL CENTER   (Israel)

Author keywords

Haemochromatosis; Haemojuvelin; Hepcidin; Iron; Thalassaemia

Indexed keywords

HEPCIDIN; LIPOCALIN2; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; ERYTHROPOIESIS; GENE EXPRESSION; HEMOCHROMATOSIS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON ABSORPTION; IRON METABOLISM; IRON OVERLOAD; LIVER CELL; NONHUMAN; ONCOGENE; PLASMA FACTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOENDOTHELIAL SYSTEM;

ACUTE-PHASE PROTEINS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-THALASSEMIA; BLOOD TRANSFUSION; CELL LINE; DOWN-REGULATION; HEMOCHROMATOSIS; HEPATOCYTES; HUMANS; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS;

EID: 33748370295     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06258.x     Document Type: Article

References (46)

1. Adamsky, K., Weizer, O., Amariglio, N., Breda, L., Harmelin, A., Rivella, S., Rachmilewitz, E. & Rechavi, G. (2004) Decreased hepcidin mRNA expression in thalassemic mice. British Journal of Haematology, 124, 123-124.
2. Ahmad, K.A., Ahmann, J.R., Migas, M.C., Waheed, A., Britton, R.S., Bacon, B.R., Sly, W.S. & Fleming, R.E. (2002) Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells, Molecules and Diseases, 29, 361-366.
3. Beutler, E. (2004) Cell biology. 'Pumping' iron: the proteins. Science, 306, 2051-2053.
4. Bridle, K.R., Frazer, D.M., Wilkins, S.J., Dixon, J.L., Purdie, D.M., Crawford, D.H., Subramaniam, V.N., Powell, L.W., Anderson, G.J. & Ramm, G.A. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet, 361, 669-673.
5. Buys, S.S., Martin, C.B., Eldridge, M., Kushner, J.P. & Kaplan, J. (1991) Iron absorption in hypotransferrinemic mice. Blood, 78, 3288-3290.
6. Cazzola, M., Beguin, Y., Bergamaschi, G., Guarnone, R., Cerani, P., Barella, S., Cao, A. & Galanello, R. (1999) Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. British Journal of Haematology, 106, 752-755.
7. Fleming, R.E., Migas, M.C., Holden, C.C., Waheed, A., Britton, R.S., Tomatsu, S., Bacon, B.R. & Sly, W.S. (2000) Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proceedings of the National Academy of Sciences of the United States of America, 97, 2214-2219.
8. Frazer, D.M., Wilkins, S.J., Becker, E.M., Vulpe, C.D., McKie, A.T., Trinder, D. & Anderson, G.J. (2002) Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology, 123, 835-844.
9. Ganz, T. (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 102, 783-788.
10. Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N. & Strong, R.K. (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Molecular Cell, 10, 1033-1043.
11. Gu, X. & Zeng, Y. (2002) A review of the molecular diagnosis of thalassemia. Hematology, 7, 203-209.
12. Huang, F.W., Pinkus, J.L., Pinkus, G.S., Fleming, M.D. & Andrews, N.C. (2005) A mouse model of juvenile hemochromatosis. The Journal of Clinical Investigation, 115, 2187-2191.
13. Inamura, J., Ikuta, K., Jimbo, J., Shindo, M., Sato, K., Torimoto, Y. & Kohgo, Y. (2005) Upregulation of hepcidin by interleukin-1beta in human hepatoma cell lines. Hepatology Research, 33, 198-205.
14. Karimi, M., Darzi, H. & Yavarian, M. (2005) Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. Journal of Pediatric Hematology/Oncology, 27, 380-385.
15. Kawabata, H., Yang, R., Hirama, T., Vuong, P.T., Kawano, S., Gombart, A.F. & Koeffler, H.P. (1999) Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. The Journal of Biological Chemistry, 274, 20826-20832.
16. Kawabata, H., Germain, R.S., Ikezoe, T., Tong, X., Green, E.M., Gombart, A.F. & Koeffler, H.P. (2001) Regulation of expression of murine transferrin receptor 2. Blood, 98, 1949-1954.
17. Kawabata, H., Fleming, R.E., Gui, D., Moon, S.Y., Saitoh, T., O'Kelly, J., Umehara, Y., Wano, Y., Said, J.W. & Koeffler, H.P. (2005) Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood, 105, 376-381.
18. Kearney, S.L., Nemeth, E., Neufeld, E.J., Thapa, D., Ganz, T., Weinstein, D.A. & Cunningham, M.J. (2005) Urinary hepcidin in congenital chronic anemias. Pediatric Blood and Cancer DOI 10.1002/pbc.20616.
19. Krause, A., Neitz, S., Magert, H.J., Schulz, A., Forssmann, W.G., Schulz-Knappe, P. & Adermann, K. (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Letters, 480, 147-150.
20. Krijt, J., Vokurka, M., Chang, K.T. & Necas, E. (2004) Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood, 104, 4308-4310.
21. Lee, P., Peng, H., Gelbart, T., Wang, L. & Beutler, E. (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proceedings of the National Academy of Sciences of the United States of America, 102, 1906-1910.
22. Lin, L., Goldberg, Y.P. & Ganz, T. (2005) Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood, 106, 2884-2889.
23. Montosi, G., Corradini, E., Garuti, C., Barelli, S., Recalcati, S., Cairo, G., Valli, L., Pignatti, E., Vecchi, C., Ferrara, F. & Pietrangelo, A. (2005) Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology, 41, 545-552.
24. Musto, P., Lombardi, G., Centra, M., Modoni, S., Carotenuto, M. & Di Giorgio, G. (1993) Soluble transferrin receptor in beta-thalassaemia. Lancet, 342, 1058.
25. Nemeth, E., Valore, E.V., Territo, M., Schiller, G., Lichtenstein, A. & Ganz, T. (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood, 101, 2461-2463.
26. Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T. & Kaplan, J. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306, 2090-2093.
27. Nemeth, E., Roetto, A., Garozzo, G., Ganz, T. & Camaschella, C. (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood, 105, 1803-1806.
28. Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A. & Vaulont, S. (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 98, 8780-8785.
29. Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A. & Vaulont, S. (2002a) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proceedings of the National Academy of Sciences of the United States of America, 99, 4596-4601.
30. Nicolas, G., Viatte, L., Bennoun, M., Beaumont, C., Kahn, A. & Vaulont, S. (2002b) Hepcidin, a new iron regulatory peptide. Blood cells, Molecules and Diseases, 29, 327-335.
31. Nicolas, G., Chauvet, C., Viatte, L., Danan, J.L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A. & Vaulont, S. (2002c) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. The Journal of Clinical Investigation, 110, 1037-1044.
32. Olivieri, N.F. & Brittenham, G.M. (1997) Iron-chelating therapy and the treatment of thalassemia. Blood, 89, 739-761.
33. Papanikolaou, G., Samuels, M.E., Ludwig, E.H., MacDonald, M.L., Franchini, P.L., Dube, M.P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., Nemeth, E., Thompson, J., Risler, J.K., Zaborowska, C., Babakaiff, R., Radomski, C.C., Pape, T.D., Davidas, O., Christakis, J., Brissot, P., Lockitch, G., Ganz, T., Hayden, M.R. & Goldberg, Y.P. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genetics, 36, 77-82.
34. Papanikolaou, G., Tzilianos, M., Christakis, J.I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y.P., Sakellaropoulos, N., Ganz, T. & Nemeth, E. (2005) Hepcidin in iron overload disorders. Blood, 105, 4103-4105.
35. Park, C.H., Valore, E.V., Waring, A.J. & Ganz, T. (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. Journal of Biological Chemistry, 276, 7806-7810.
36. Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P. & Loreal, O. (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. Journal of Biological Chemistry, 276, 7811-7819.
37. Pootrakul, P., Kitcharoen, K., Yansukon, P., Wasi, P., Fucharoen, S., Charoenlarp, P., Brittenham, G., Pippard, M.J. & Finch, C.A. (1988) The effect of erythroid hyperplasia on iron balance. Blood, 71, 1124-1129.
38. Punnonen, K., Irjala, K. & Rajamaki, A. (1997) Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood, 89, 1052-1057.
39. Robb, A. & Wessling-Resnick, M. (2004) Regulation of transferrin receptor 2 protein levels by transferrin. Blood, 104, 4294-4299.
40. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D. & Camaschella, C. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nature Genetics, 33, 21-22.
41. Roy, C.N., Weinstein, D.A. & Andrews, N.C. (2003) 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatric Research, 53, 507-512.
42. Rund, D. & Rachmilewitz, E. (2005) β-Thalassemia. The New England Journal of Medicine, 353, 1135-1146.
43. Weatherall, D.J., Pressley, L., Wood, W.G., Higgs, D.R. & Clegg, J.B. (1981) Molecular basis for mild forms of homozygous beta-thalassaemia. Lancet, 1, 527-529.
44. Weinstein, D.A., Roy, C.N., Fleming, M.D., Loda, M.F., Wolfsdorf, J.I. & Andrews, N.C. (2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood, 100, 3776-3781.
45. Weizer-Stern, O., Adamsky, K., Amariglio, N., Rachmilewitz, E., Breda, L., Rivella, S. & Rechavi, G. (2006) mRNA expression of iron regulatory genes in β-thalassemia intermedia and β-thalassemia major mouse models. American Journal of Hematology, 81, 479-483.
46. Yang, J., Mori, K., Li, J.Y. & Barasch, J. (2003) Iron, lipocalin, and kidney epithelia. American Journal of Physiology and Renal Physiology, 285, F9-F18.